Literature DB >> 23253323

Anti-adhesion methods as novel therapeutics for bacterial infections.

Daniel Cozens1, Robert C Read.   

Abstract

Anti-adhesion therapies for bacterial infections offer an alternative to antibiotics, with those therapies bacteria are not killed but are prevented from causing harm to a host by inhibiting adherence to host cells and tissues, a prerequisite for the majority of infectious diseases. The mechanisms of these potential therapeutic agents include inhibition of adhesins and their host receptors, vaccination with adhesins or analogs, use of probiotics and dietary supplements that interfere with receptor-adhesin interactions, subminimal inhibitory concentrations of antibiotics and manipulation of hydrophobic interactions. Once developed, these drugs will contribute to the arsenal for fighting infectious disease in the future, potentially subverting antibiotic resistance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23253323     DOI: 10.1586/eri.12.145

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  31 in total

1.  Characterization of BCAM0224, a multifunctional trimeric autotransporter from the human pathogen Burkholderia cenocepacia.

Authors:  Dalila Mil-Homens; Maria Inês Leça; Fábio Fernandes; Sandra N Pinto; Arsenio M Fialho
Journal:  J Bacteriol       Date:  2014-03-21       Impact factor: 3.490

2.  Molecular interactions and inhibition of the staphylococcal biofilm-forming protein SdrC.

Authors:  Cécile Feuillie; Cécile Formosa-Dague; Leanne M C Hays; Ophélie Vervaeck; Sylvie Derclaye; Marian P Brennan; Timothy J Foster; Joan A Geoghegan; Yves F Dufrêne
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

3.  The human IgG anti-carbohydrate repertoire exhibits a universal architecture and contains specificity for microbial attachment sites.

Authors:  Christoph Schneider; David F Smith; Richard D Cummings; Kayluz Frias Boligan; Robert G Hamilton; Bruce S Bochner; Sylvia Miescher; Hans-Uwe Simon; Anastas Pashov; Tchavdar Vassilev; Stephan von Gunten
Journal:  Sci Transl Med       Date:  2015-01-07       Impact factor: 17.956

Review 4.  Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease.

Authors:  Laurel K Mydock-McGrane; Thomas J Hannan; James W Janetka
Journal:  Expert Opin Drug Discov       Date:  2017-06-02       Impact factor: 6.098

Review 5.  Targeting microbial biofilms: current and prospective therapeutic strategies.

Authors:  Hyun Koo; Raymond N Allan; Robert P Howlin; Paul Stoodley; Luanne Hall-Stoodley
Journal:  Nat Rev Microbiol       Date:  2017-09-25       Impact factor: 60.633

6.  Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by lactoferrin.

Authors:  Maria I Quintero-Villegas; Anja Wittke; Robert Hutkins
Journal:  Curr Microbiol       Date:  2014-06-14       Impact factor: 2.188

Review 7.  A review on anti-adhesion therapies of bacterial diseases.

Authors:  Arezoo Asadi; Shabnam Razavi; Malihe Talebi; Mehrdad Gholami
Journal:  Infection       Date:  2018-10-01       Impact factor: 3.553

8.  The binding mechanism of the virulence factor Streptococcus suis adhesin P subtype to globotetraosylceramide is associated with systemic disease.

Authors:  Miralda Madar Johansson; Eva Bélurier; Anastassios C Papageorgiou; Anders P Sundin; Jani Rahkila; Teemu Kallonen; Ulf J Nilsson; Santeri Maatsola; Thomas K M Nyholm; Jarmo Käpylä; Jukka Corander; Reko Leino; Jukka Finne; Susann Teneberg; Sauli Haataja
Journal:  J Biol Chem       Date:  2020-08-12       Impact factor: 5.157

9.  The Synthesis and Evaluation of Multivalent Glycopeptoids as Inhibitors of the Adhesion of Candida albicans.

Authors:  Harlei Martin; Hannah Masterson; Kevin Kavanagh; Trinidad Velasco-Torrijos
Journal:  Pathogens       Date:  2021-05-08

10.  Structure based virtual screening identifies small molecule effectors for the sialoglycan binding protein Hsa.

Authors:  Rupesh Agarwal; Barbara A Bensing; Dehui Mi; Paige N Vinson; Jerome Baudry; Tina M Iverson; Jeremy C Smith
Journal:  Biochem J       Date:  2020-10-16       Impact factor: 3.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.